title: The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey.
abstract: The efficacy of an outer surface protein A (OspA) vaccine in three different formulations was investigated in the rhesus monkey. The challenge infection was administered using Ixodes scapularis ticks that were infected with the B31 strain of Borrelia burgdorferi. Protection was assessed against both infection and disease, by a variety of procedures. Some of the animals were radically immune suppressed, as an attempt to reveal any putative low level infection in the vaccinated animals. The significant difference found between the spirochaetal infection rates of ticks that had fed on vaccinated vs. control monkeys, lack of seroconversion in the vaccinated animals, and the absence of spirochaetal DNA in the skin of vaccinated animals in the weeks following the challenge, indicate that vaccinated monkeys were protected against tick challenge. The post-mortem immunohistochemical and polymerase chain reaction analyses, however, suggest that these monkeys may have undergone a low-level infection that was transient.
authors.affiliation: Tulane University Medical Center, Tulane Regional Primate Research Center, Covington, LA, USA. philipp@tpc.tulane.edu
authors.forename: M T
authors.initials: MT
authors.lastname: Philipp
authors.forename: Y
authors.initials: Y
authors.lastname: Lobet
authors.forename: R P
authors.initials: RP
authors.lastname: Bohm
authors.forename: E D
authors.initials: ED
authors.lastname: Roberts
authors.forename: V A
authors.initials: VA
authors.lastname: Dennis
authors.forename: Y
authors.initials: Y
authors.lastname: Gu
authors.forename: R C
authors.initials: RC
authors.lastname: Lowrie
authors.forename: P
authors.initials: P
authors.lastname: Desmons
authors.forename: P H
authors.initials: PH
authors.lastname: Duray
authors.forename: J D
authors.initials: JD
authors.lastname: England
authors.forename: P
authors.initials: P
authors.lastname: Hauser
authors.forename: J
authors.initials: J
authors.lastname: Piesman
authors.forename: K
authors.initials: K
authors.lastname: Xu
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis / Q000097:blood; D000954:Antigens, Surface / Q000276:immunology*; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology*; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D001706:Biopsy; D015153:Blotting, Western; D015748:Borrelia burgdorferi Group / Q000276:immunology; D001921:Brain / Q000382:microbiology / Q000473:pathology; D004562:Electrocardiography; D007150:Immunohistochemistry; D007165:Immunosuppression Therapy; D018884:Ixodes / Q000382:microbiology; D008074:Lipoproteins; D008193:Lyme Disease / Q000097:blood / Q000473:pathology / Q000517:prevention & control*; D008253:Macaca mulatta; D008297:Male; D009431:Neural Conduction / Q000502:physiology; D016133:Polymerase Chain Reaction; D011994:Recombinant Proteins / Q000276:immunology; D016622:Silver Staining; D012867:Skin / Q000737:chemistry / Q000382:microbiology / Q000473:pathology
chemical_list: D000907:Antibodies, Bacterial; D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D008074:Lipoproteins; C072045:OspA protein; D011994:Recombinant Proteins